Examining how tucking affects semen quality in trans women
The Effect of Tucking on Semen Quality of Adult Trans Women Compared to Semen Quality of Trans Women Who do Not Tuck - a Case Control Study
This study is testing how tucking affects sperm quality in trans women who want to preserve their fertility before starting hormone therapy.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 40 (estimated) |
| Ages | 18 Years to 50 Years |
| Sex | Male |
| Sponsor | Medical University Innsbruck Academic / other |
| Locations | 1 site (Innsbruck) |
| Trial ID | NCT06530992 on ClinicalTrials.gov |
What this trial studies
This observational study investigates the impact of tucking on semen quality in adult trans women, particularly in the context of fertility preservation prior to starting gender-affirming hormone therapy (GAHT). It aims to analyze the effects of tucking, a method used to minimize crotch bulge, on sperm concentration and motility. The study will involve female transgender patients aged 18 to 50 who are eligible for GAHT and will assess their semen quality before and during the practice of tucking. The findings could provide valuable insights into fertility issues faced by trans women.
Who should consider this trial
Good fit: Ideal candidates for this study are female transgender individuals aged 18 to 50 who are preparing to start gender-affirming hormone therapy.
Not a fit: Patients who are undergoing ongoing gender-affirming genital surgery or have conditions like hypogonadism or diabetes may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could help inform trans women about the effects of tucking on their fertility and guide them in making decisions about fertility preservation.
How similar studies have performed: While there have been studies on semen quality in trans women, the specific focus on tucking and its effects on fertility is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Female transgender patients between the ages of 18 to 50 years of age who are seen at the University Clinic for Gyn. Endocrinology and Reproductive Medicine of the Medical University of Innsbruck. Patients must have met the eligibility and readiness criteria for gender-affirming hormone therapy Exclusion Criteria: * Ongoing GAHT gender affirming genital surgery Hypogonadism Diabetes mellitus Cystic Fibrosis Varicocele Cryptorchism Post-sterilization Incapacity to consent
Where this trial is running
Innsbruck
- University clinic for Gynecological Endocrinology and Reproductive Medicine Department of Gynecology Medical University of Innsbruck — Innsbruck, Austria (Recruiting)
Study contacts
- Study coordinator: Katharina Feil, MD
- Email: katharina.feil@i-med.ac.at
- Phone: +4351250425657
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.